Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for screening traditional Chinese medicines influencing drug resistance of escherichia coil generating ESBLs (extended spectyum beta lactamase)

A technology of Escherichia coli and drug resistance, which is applied in the field of traditional Chinese medicine screening that affects drug resistance of ESBLs-producing Escherichia coli, can solve the problems of narrowing the screening range of traditional Chinese medicine, difficulty in judging the accuracy of results, and slow screening speed, so as to avoid sterilization The conflict between the effect and drug resistance reversal effect, the effect of expanding the type and scope of screening, and the convenience of operation

Active Publication Date: 2013-06-12
GUANGXI UNIV
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, using the above two methods for screening, only Chinese medicines that do not affect the growth of bacteria can be screened out, which seriously reduces the scope of screening Chinese medicines. In addition, it is difficult to judge the duration of action during screening, slow screening speed, cumbersome operations and accurate results. Sexual Difficulty Disadvantages

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for screening traditional Chinese medicines influencing drug resistance of escherichia coil generating ESBLs (extended spectyum beta lactamase)
  • Method for screening traditional Chinese medicines influencing drug resistance of escherichia coil generating ESBLs (extended spectyum beta lactamase)
  • Method for screening traditional Chinese medicines influencing drug resistance of escherichia coil generating ESBLs (extended spectyum beta lactamase)

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] The screening of Zeilan traditional Chinese medicine that has drug resistance reversal effect on TEM-producing Escherichia coli is carried out according to the following steps:

[0021] (1) Use the conventional ESBLs-producing Escherichia coli primary screening method to screen the enzyme-producing strains, and then use the PCR amplification method to confirm that the ESBLs-producing type is TEM type, and save it for future use;

[0022] (2) In the first batch of 96-well plates, the sub-inhibitory concentration of E. coli strains resistant to ESBLs was determined by using the double-dilution method of micro-tubes, and the minimum inhibitory concentration of western medicine was determined. The western medicine was Amo Penicillin, ciprofloxacin, norfloxacin, levofloxacin, clinfloxacin, sulfamethoxine sodium, gatifloxacin, and florfenicol.

[0023] (3) According to the sub-inhibitory concentration of Eupatorium obtained in step (2), after adding the sub-inhibitory concent...

Embodiment 2

[0031] The screening of the traditional Chinese medicine that has drug-resistant reversal effect on CTX-M-producing Escherichia coli is carried out according to the following steps:

[0032] (1) The enzyme-producing strains were screened by conventional ESBLs-producing Escherichia coli screening method, and then confirmed by PCR amplification that the ESBLs-producing type was CTX-M, and stored for future use;

[0033] (2) On the first batch of 96-well plates, the sub-inhibitory concentration of Escherichia coli strains resistant to ESBLs and the minimum inhibitory concentration of Western medicine were determined by using the double-dilution method of micro test tubes, and the western medicine was Amo Xilin, Norfloxacin, Levofloxacin, Shigaojing, Clinfloxacin, Sulfamethoxine Sodium, Gatifloxacin, and Florfenicol.

[0034] (3) According to the sub-inhibitory concentration of baubing obtained in step (2), after adding the sub-inhibitory concentration of baubing in the culture me...

Embodiment 3

[0042] The screening of Escherichia coli traditional Chinese medicine with drug-resistant reversal effect on TEM and CTX-M Escherichia coli is carried out according to the following steps:

[0043] (1) The enzyme-producing strains were screened by conventional ESBLs-producing E. coli screening methods, and then confirmed by PCR amplification that the types of ESBLs produced were TEM and CTX-M, and stored for future use;

[0044] (2) On the first batch of 96-well plates, the sub-inhibitory concentration of Escherichia coli against drug-resistant ESBLs-producing Escherichia coli strains was determined by using the micro-tube double dilution method, and the minimum inhibitory concentration of western medicine was determined. The western medicine is cephalosporin Trixone sodium, amoxicillin, amikacin, doxycycline, ciprofloxacin, and norfloxacin.

[0045] (3) According to the sub-inhibitory concentration of P. chinensis obtained in step (2), after adding the sub-inhibitory concentr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for screening traditional Chinese medicines influencing the drug resistance of escherichia coil generating ESBLs (extended spectyum beta lactamase). The method comprises the following steps of: determining the minimum inhibitory concentrations of western medicines and traditional Chinese medicines to escherichia coil strains generating ESBLs through adopting a microtest tube double broth dilution method on a 96-well cell culture plate, then adding the traditional Chinese medicines with the sub minimum inhibitory concentrations into a culture medium, and culturing and determining the minimum inhibitory concentrations of the western medicines through using the microtest tube double broth dilution method again; and subculturing in the culture medium added with the traditional Chinese medicines with the same sub minimum inhibitory concentrations and the western medicines with the same concentrations through utilizing a continuous passage method until observing that the sub minimum inhibitory concentrations of the western medicines are reduced by more than 4 times than those before the passage culture, and thus judging that the traditional Chinese medicines have multidrug-resistant reversion functions on the western medicines. The method is not limited by the culture possibility of bacteria which are effected by the traditional Chinese medicines, the bactericidal effect and multidrug-resistant reversion function of the traditional Chinese medicines are not interfered with each other, so that the screening type and scope of the traditional Chinese medicines are broadened; and the method is convenient to operate, and the screening result can be accurately and quickly determined.

Description

technical field [0001] The invention relates to a method for screening traditional Chinese medicines affecting drug resistance of ESBLs-producing Escherichia coli. Background technique [0002] Escherichia coli is a common conditional pathogen, which can cause acute sepsis, peritonitis, hepatitis, pneumonia, enteritis and other severe infections in chickens, and can also be secondary or mixed with viral diseases, causing huge economic losses to the breeding industry. loss. Among them, amoxicillin, ampicillin, ceftiofur, ceftriaxone, amoxicillin / clavulanic acid, ampicillin / sulbactam and other β-lactam ring antibiotics are commonly used important drugs for the prevention and treatment of the disease. The scale of breeding is becoming more and more intensive, the use of drugs is becoming more and more widespread, and there are more and more drug-resistant strains. There are many reports on drug resistance of Escherichia coli. Current research has confirmed that one of the main...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/18
Inventor 司红彬黄凯夏娟蒋利和何家康何山红王秋华梁晶晶郑艳青宋剑武
Owner GUANGXI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products